Improving the Quality of Prenatal Care for Low-Income, Black Women

提高低收入黑人女性的产前护理质量

基本信息

项目摘要

PROJECT SUMMARY/ABSTRACT: PROJECT 5 (SMITH) Background: The U.S. has the highest rate of maternal deaths in the developed world and over 60% of maternal deaths in the U.S. are preventable. Preeclampsia, a disorder of pregnancy characterized by hypertension and proteinuria, is a top preventable cause of maternal death and an important driver of health disparities in the U.S. Chronic hypertension, a major risk factor for preeclampsia, is estimated to be present in 3% to 5% of all pregnancies but is 60% more prevalent in Black women. Black women carry a 3- to 4-fold greater risk, compared to Whites, of dying from preeclampsia. Research suggest that women at high-risk for preeclampsia recieve 81 to 150 mg of aspirin and counseling on and self-monitor their high blood pressure between 11-16 until 36 weeks of gestation. The brief duration of typical prenatal visits (10 minutes on average) hinders the provider’s ability to deliver evidence-based preeclampsia education and counseling. To date, current research does not, moreover, take advantage of innovative and evidence-based models of prenatal care and hypertension control that have proven feasible for providers and patients. Thus, there is a critical need to implement and deliver guideline-consistent preeclampsia prevention in a sustainable model that removes barriers to care for at-risk Black women. Study Design: The long-term goal of this project is to reduce needless preeclampsia and preeclampsia-related deaths among Black pregnant women by increasing access to evidence-based care. The objective of this study is to refine and pilot test a novel intervention that is designed to address patient and provider barriers to preeclampsia prevention. The intervention, Centering HER (Health, Empowerment, and Reproduction), combines a well-established and effective group prenatal care model—Centering Pregnancy—with a promising telemedicine-based hypertension control program—Take Control of Your Blood Pressure. To meet our study objective, the study proposes the following specific aims: 1) To gain end-user input on the feasibility and acceptability of Centering HER, 2) To pilot the revised Centering HER and collect feasibility and intermediate outcome data, and 3) To determine the effectiveness of Centering HER to improve blood pressure monitoring, aspirin adherence, and implementation measures. Potential Impact: The successful completion of the aims will be important to address the cornerstones of preeclampsia prevention –prenatal care, medication adherence, and blood pressure monitoring and reduce maternal health disparities. If efficacious, Centering HER may be a low cost, sustainable, translatable option ot prevent preeclampsia in at-risk populations.
项目摘要/摘要:项目5(史密斯) 背景:美国的孕产妇死亡率是发达国家中最高的,超过60%的 在美国,孕产妇死亡是可以预防的。先兆子痫,一种妊娠障碍,其特征是 高血压和蛋白尿是孕产妇死亡的首要可预防原因,也是健康的重要驱动因素 美国慢性高血压是先兆子痫的主要危险因素,据估计, 3%到5%的怀孕,但在黑人女性中发病率高出60%。黑人女性携带着3到4倍的 与白人相比,死于先兆子痫的风险更大。研究表明,患高血压的高危女性 先兆子痫接受81至150毫克阿司匹林治疗,并对其高血压进行咨询和自我监测 妊娠11-16周至36周。典型产前检查的短暂持续时间(平均10分钟) 妨碍提供者提供以证据为基础的子痫前期教育和咨询的能力。到目前为止, 此外,目前的研究没有利用创新的和基于证据的产前模式 护理和高血压控制已被证明对提供者和患者是可行的。因此,有一个关键的 需要以可持续的模式实施和提供指南一致的先兆子痫预防 消除了照顾高危黑人妇女的障碍。研究设计:该项目的长期目标是减少 通过增加机会增加黑人孕妇中不必要的先兆子痫和先兆子痫相关死亡 以证据为基础的护理。这项研究的目的是提炼和试行一种新的干预措施,即 旨在解决患者和提供者在预防先兆子痫方面的障碍。干预,以她为中心 (健康、赋权和生殖),结合了一组完善和有效的产前护理 以怀孕为中心的模型-有前景的基于远程医疗的高血压控制计划-Take 控制你的血压。为了达到我们的研究目标,研究提出了以下具体目标:1) 为获得最终用户对居中的可行性和可接受性的意见,2)试行修订后的居中 HER并收集可行性和中期结果数据,以及3)确定居中的有效性 她提出了改善血压监测、阿司匹林依从性等实施措施。潜力 影响:成功完成目标对于解决先兆子痫的基石将是重要的 预防--产前护理、服药依从性和血压监测,降低产妇健康 差距。如果有效,以她为中心可能是一个低成本、可持续、可翻译的预防选择 高危人群中的先兆子痫。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Sharla Annette Smith其他文献

Sharla Annette Smith的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Sharla Annette Smith', 18)}}的其他基金

Improving the Quality of Prenatal Care for Low-Income, Urban, Black Women
提高低收入城市黑人妇女的产前护理质量
  • 批准号:
    10308472
  • 财政年份:
    2019
  • 资助金额:
    $ 24.24万
  • 项目类别:
Improving the Quality of Prenatal Care for Low-Income, Urban, Black Women
提高低收入城市黑人妇女的产前护理质量
  • 批准号:
    10539277
  • 财政年份:
    2019
  • 资助金额:
    $ 24.24万
  • 项目类别:
Improving the Quality of Prenatal Care for Low-Income, Urban, Black Women
提高低收入城市黑人妇女的产前护理质量
  • 批准号:
    10065518
  • 财政年份:
    2019
  • 资助金额:
    $ 24.24万
  • 项目类别:

相似海外基金

An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
  • 批准号:
    10057526
  • 财政年份:
    2023
  • 资助金额:
    $ 24.24万
  • 项目类别:
    Grant for R&D
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
  • 批准号:
    490105
  • 财政年份:
    2023
  • 资助金额:
    $ 24.24万
  • 项目类别:
    Operating Grants
I-Corps: Medication Adherence System
I-Corps:药物依从性系统
  • 批准号:
    2325465
  • 财政年份:
    2023
  • 资助金额:
    $ 24.24万
  • 项目类别:
    Standard Grant
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
  • 批准号:
    10821172
  • 财政年份:
    2023
  • 资助金额:
    $ 24.24万
  • 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
  • 批准号:
    10766947
  • 财政年份:
    2023
  • 资助金额:
    $ 24.24万
  • 项目类别:
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
  • 批准号:
    10772887
  • 财政年份:
    2023
  • 资助金额:
    $ 24.24万
  • 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
  • 批准号:
    10594350
  • 财政年份:
    2023
  • 资助金额:
    $ 24.24万
  • 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
  • 批准号:
    10748465
  • 财政年份:
    2023
  • 资助金额:
    $ 24.24万
  • 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
  • 批准号:
    10591441
  • 财政年份:
    2023
  • 资助金额:
    $ 24.24万
  • 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
  • 批准号:
    491109
  • 财政年份:
    2023
  • 资助金额:
    $ 24.24万
  • 项目类别:
    Fellowship Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了